- A Case of Bernard-Soulier Syndrome Associated with 22q11.2 Deletion Syndrome
-
Kwon OC, Yoon SH, Kang SH, Kim H, Koh KN, Im HJ
- KMID: 2547554
- Clin Pediatr Hematol Oncol.
- 2023 Oct;30(2):95-98.
- doi: 10.15264/cpho.2023.30.2.95
22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by microdeletions in the long arm of chromosome 22. It is one of the most common chromosomal microdeletion disorders. Clinical symptoms are... -
- CITED
-
- Close
- SHARE
-
- Close
- A Cross Sectional Study of High-Alert Medications and Their Potential Harm in Acute Care Settings
-
Lee AY, Han JM, Jeong J, Lee S, Heo KN, Park S, Chae H, Min Si, Ah YM, Lee JY
- KMID: 2551233
- Pharmacoepidemiol Risk Manage.
- 2023 Sep;15(2):165-171.
- doi: 10.56142/perm.23.0016
Objective: In this study, we aimed to analyze national claims data to assess the usage of high-alert medications among hospitalized patients and to identify associated potential harm. Methods: This study... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study
-
Kim BW, Park JJ, Moon HS, Lee WS, Shim KN, Baik GH, Lim YJ, Lee HL, Youn YH, Park JC, Sung IK, Chung H, Moon JS, Kim GH, Hong SJ, Choi HS
- KMID: 2553834
- Gut Liver.
- 2024 Mar;18(2):257-264.
- doi: 10.5009/gnl230242
Background/Aims: Tegoprazan is a novel potassium-competitive acid blocker that has beneficial effects on acid-related disorders such as gastroesophageal reflux and peptic ulcer diseases. This study aimed to validate the effect of... -
- CITED
-
- Close
- SHARE
-
- Close
